Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer
Abstract Background Cuproptosis is a novel form of cell death, acting on the tricarboxylic acid cycle in mitochondrial respiration and mediated by protein lipoylation. Other cancer cell death processes, such as necroptosis, pyroptosis, and ferroptosis, have been shown to play crucial roles in the th...
Saved in:
Main Authors: | Wei Tan, Fangfang Dai, Qinyu Ci, Zhimin Deng, Hua Liu, Yanxiang Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Women's Health |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12905-024-03519-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cuproptosis: molecular mechanisms, cancer prognosis, and therapeutic applications
by: Yating Cong, et al.
Published: (2025-01-01) -
Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
by: Ziwei Gao, et al.
Published: (2025-01-01) -
Machine learning-random forest model was used to construct gene signature associated with cuproptosis to predict the prognosis of gastric cancer
by: Xiaolong Liu, et al.
Published: (2025-02-01) -
Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer
by: Shuo-Fu Chen, et al.
Published: (2024-09-01) -
Targeting the initiator to activate both ferroptosis and cuproptosis for breast cancer treatment: progress and possibility for clinical application
by: Murshid Imam, et al.
Published: (2025-01-01)